1 x Tirzepatide 2.5mg

Contents

• 1 x Tirzepatide 2.5mg
• 1 x Syringe
• 1 x Water
• 1 x Pre-Injection Swab

What is Tirzepatide?

Tirzepatide is a dual-acting GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist used primarily for the treatment of Type 2 diabetes and obesity. Administered via subcutaneous injection, tirzepatide works to regulate blood sugar levels and promote weight loss.

Tirzepatide Mixing & Doasage

Mixing

Adding the following amount of water will give you a concentration of 0.5mg per 0.1ml or 10 units on the syringe.

• Tirzepatide 2.5mg – 0.5ml

Adding the following amount of water will give you a concentration of 1mg per 0.1ml or 10 units on the syringe.

• Tirzepatide 5mg – 0.5ml
• Tirzepatide 10mg – 1ml
• Tirzepatide 20mg – 2ml

Dosage

Note: This is a general guide. Consult your healthcare provider for personalized advice.

Recommended Dosage Schedule:

1. Initiation Phase:

To minimize gastrointestinal side effects (nausea, vomiting, diarrhea), the initial dose is low and gradually increased.

• Week 1-4:

• Starting dose: 2.5 mg subcutaneously once per week

2. Titration Phase:

Gradual dose escalation over several weeks improves tolerance.

• Week 5-8:

• Increase dose to 5 mg subcutaneously once per week

• Optional Dose Increases: (if no significant side effects and based on healthcare advice)

• Week 9-12: 7.5 mg/week

• Week 13-16: 10 mg/week

• Week 17 onward (if needed): 12.5 mg or 15 mg once per week

Maintenance Dose:

• The maintenance dose typically ranges from 5 mg to 15 mg weekly, depending on the patient’s response and treatment goals (e.g., blood sugar control, weight loss).

• Maximum Dose: 15 mg once per week

Injection Instructions:

Subcutaneous Injection Sites:

• Rotate between the abdomen, thigh, or upper arm.

• Avoid injecting into areas with scars, stretch marks, or irritation.

Timing:

• Inject once a week, at the same time each week.

• Can be taken with or without food.

Missed Dose:

• If a dose is missed, administer within 4 days. If more than 4 days have passed, skip the dose and resume the next scheduled injection.

Common Side Effects:

• Gastrointestinal: Nausea, diarrhea, constipation, vomiting

• Others: Reduced appetite, mild fatigue

These side effects typically diminish as the body adjusts to the medication.

Storage:

• Keep tirzepatide in the refrigerator (36°F to 46°F / 2°C to 8°C).

• Protect from light and avoid freezing.

• May be kept at room temperature (up to 86°F / 30°C) for up to 14 days if needed.

Important Considerations:

• Monitoring: Regular blood sugar monitoring and weight tracking are essential.

• Individualization: Dosage adjustments depend on clinical goals, treatment response, and side effect tolerance.

• Avoid Alcohol: Excessive alcohol may increase the risk of hypoglycemia.

• Drug Interactions: Discuss any other medications or supplements with your healthcare provider.

Always consult your healthcare provider before starting or adjusting tirzepatide to ensure safety and efficacy.